Role of Cervical Cancer Biomarkers p16 and Ki67 in Abnormal Cervical Cytological Smear
- PMID: 33814802
- PMCID: PMC7960869
- DOI: 10.1007/s13224-020-01380-y
Role of Cervical Cancer Biomarkers p16 and Ki67 in Abnormal Cervical Cytological Smear
Abstract
Introduction: Cervical cancer is the most common cancer in India. Screening for cervical cancer helps in marked reduction of invasive cervical cancers. The low sensitivity of Papanicolaou cytology (Pap smear) and high-risk human papillomavirus (HR-HPV) in excluding high-grade intraepithelial lesion (ASC-H) leads to unnecessary referrals to colposcopy-guided biopsy. The combined cervical cytology screening and HR-HPV have its own limitations and still need further standardization. Using additional biomarkers like staining with p16 and Ki-67 might help in triaging abnormal pap smear.
Materials and methods: A prospective, cross-sectional study was performed over a period of 16 months in the Department of Obstetrics and Gynaecology, in collaboration with Department of Pathology. Study was conducted to know the efficacy of immunostaining with p16/Ki-67 in predicting the presence of significant lesion in cases of mild cytological atypia. PAP smears (conventional and LBC) along with P16, Ki-67 and available biopsies were correlated.
Results: Liquid-based cytology (LBC) was done in 2134 cases, out of which 46 cases showed abnormal cytological findings such as [22 atypical squamous cells of undetermined significance (ASCUS), 3 low-grade squamous intraepithelial lesion (LSIL), 8 atypical squamous cells cannot exclude high-grade lesion (ASC-H), 6 high-grade squamous intraepithelial lesion (HSIL), 5 squamous cell carcinoma (SCC), 2 adenocarcinoma, 1 atypical glandular cells of undetermined significance (AGUS)]. Immunostaining with p16 and Ki-67 was performed on 38 cases of abnormal cytological smears. Out of 38 abnormal cytology cases, 28 cases had shown co-staining for both p16 and Ki-67, suggestive of true HPV infection of the cells. Of the 38 cases, 07/14 ASCUS, 06/06 HSIL, 07/08 ASC-H, 05/05 squamous cell carcinoma and 02/02 adenocarcinoma also showed dual positivity for p16 and Ki-67. One case of AGUS was diagnosed, but the smear was unsatisfactory for immunocytochemical evaluation and excluded from the study. Three cases of LSIL were also diagnosed on cytological evaluation, and 1 of them however showed positivity for p16 and Ki-67 on immunocytochemistry (ICC). In the ASC-US group, the sensitivity and specificity of the immunostaining in diagnosing CIN2 + lesions were 87.51%, and in LSIL group, the sensitivity and specificity of the immunostaining in diagnosing CIN2 + lesions were 100%. p16/Ki-67 positivity also increased with cytological severity which in turn corresponded with histological findings: it reached from 50% in ASC-US to 100% in both HSIL and SCC categories.
Conclusion: This immunostaining with p16 and Ki67 can be a useful method in the triaging of the ASC-US and the LSIL group as considering the high sensitivity and specificity values.
Keywords: ASC-US; ICC; Ki67; Liquid-based cytology; p16.
© Federation of Obstetric & Gynecological Societies of India 2020.
Conflict of interest statement
Conflict of interestNone declared.
Figures
Similar articles
-
P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women.Asian Pac J Cancer Prev. 2022 Oct 1;23(10):3405-3411. doi: 10.31557/APJCP.2022.23.10.3405. Asian Pac J Cancer Prev. 2022. PMID: 36308365 Free PMC article.
-
Improved abnormal Pap smear triage using cervical cancer biomarkers.J Low Genit Tract Dis. 2014 Jan;18(1):1-7. doi: 10.1097/LGT.0b013e31828aeb39. J Low Genit Tract Dis. 2014. PMID: 23760145
-
Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results.Cancer Cytopathol. 2015 Jun;123(6):373-81. doi: 10.1002/cncy.21542. Epub 2015 Apr 17. Cancer Cytopathol. 2015. PMID: 25891096
-
The Role of p16/Ki-67 Immunostaining, hTERC Amplification and Fibronectin in Predicting Cervical Cancer Progression: A Systematic Review.Biology (Basel). 2022 Jun 23;11(7):956. doi: 10.3390/biology11070956. Biology (Basel). 2022. PMID: 36101337 Free PMC article. Review.
-
Role of immunocytochemistry in cervical cancer screening.Cytojournal. 2022 Jun 14;19:42. doi: 10.25259/CMAS_03_17_2022. eCollection 2022. Cytojournal. 2022. PMID: 35928527 Free PMC article. Review.
Cited by
-
Study on the correlation between energy spectrum computed tomography imaging and the pathological characteristics and prognosis of cervical cancer.Transl Cancer Res. 2021 Sep;10(9):4096-4105. doi: 10.21037/tcr-21-1320. Transl Cancer Res. 2021. PMID: 35116707 Free PMC article.
-
Hyperactive Ras disrupts cell size control and a key step in cell cycle entry in budding yeast.Genetics. 2023 Oct 4;225(2):iyad144. doi: 10.1093/genetics/iyad144. Genetics. 2023. PMID: 37531631 Free PMC article.
-
Cervical Lesion Evaluation in Females of Reproductive Age in Ondo Town, Nigeria.Niger Med J. 2025 Jun 16;66(2):407-419. doi: 10.71480/nmj.v66i2.357. eCollection 2025 Mar-Apr. Niger Med J. 2025. PMID: 40703876 Free PMC article.
-
Expression of oncogenic HRAS G12V causes defects in control of cell size in NIH 3T3 cells.MicroPubl Biol. 2023 Nov 2;2023:10.17912/micropub.biology.000873. doi: 10.17912/micropub.biology.000873. eCollection 2023. MicroPubl Biol. 2023. PMID: 38021173 Free PMC article.
-
Immunohistochemistry for Skin Cancers: A Comprehensive Approach to the Diagnosis of Squamous Cell Carcinoma.Cancers (Basel). 2025 May 12;17(10):1629. doi: 10.3390/cancers17101629. Cancers (Basel). 2025. PMID: 40427131 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous